CAN MUTATIONS OF EGFR AND KRAS OF SERUM BE PREDICTIVE AND PROGNOSTIC MARKERS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)?

Kim, S. T.; Kim, Y. H.

doi:10.1097/JTO.0b013e318253d2ff

Detailed Information

Cited 0 time in webofscience

Cited 0 time in scopus

Metadata Downloads

CAN MUTATIONS OF EGFR AND KRAS OF SERUM BE PREDICTIVE AND PROGNOSTIC MARKERS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)?

Authors: Kim, S. T.; Kim, Y. H.

Issue Date: 201206

URI: https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/48961

DOI: 10.1097/JTO.0b013e318253d2ff

Conference Name: JOURNAL OF THORACIC ONCOLOGY

Place: 미국
Geneva, SWITZERLAND

Conference Name: 3rd European Lung Cancer Conference (ELCC)

ISSN: 1556-0864
1556-1380

Files in This Item: There are no files associated with this item.

Appears in Collections: 2. Clinical Science > Department of Medical Oncology and Hematology > 2. Conference Papers

Show full item record

qrcode

Altmetrics

Total Views & Downloads

STATISTICS: Total View :13,044,195; Today View :722

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Altmetrics

Total Views & Downloads

BROWSE